[Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity].

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia (2003) 4.31

Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol (1994) 2.14

Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype. Cancer Genet Cytogenet (1995) 1.80

Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications. Leukemia (2006) 1.74

Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia. Arch Dis Child (1998) 1.67

Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg (1992) 1.59

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia (2000) 1.56

Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO) Acta Paediatr (1998) 1.53

The bone-marrow infiltration pattern in B-cell chronic lymphocytic leukemia is not an important prognostic factor. Danish CLL Study Group. Eur J Haematol (1996) 1.45

Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood (1998) 1.42

[Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation]. Ugeskr Laeger (1992) 1.38

Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer (1991) 1.27

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. Br J Cancer (2012) 1.24

Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. Eur J Haematol (2000) 1.22

Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials. Leukemia (2005) 1.18

Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med (1983) 1.16

Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res (1999) 1.07

Skeletal scintigraphy and radiography at onset of acute lymphocytic leukemia in children. Med Pediatr Oncol (1983) 1.07

Interferon enhances the antibody-dependent cellular cytotoxicity (ADCC) of human polymorphonuclear leukocytes. J Immunol (1981) 1.04

Reproduction following treatment for childhood leukemia: a population-based prospective cohort study of fertility and offspring. Med Pediatr Oncol (1991) 1.00

Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol (1998) 1.00

DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology? Blood (2000) 0.99

Analysis of leucocyte differentiation antigens in blood and bone marrow from patients with Waldenström's macroglobulinaemia. Br J Haematol (1987) 0.99

Age-dependent variations in serum 1,25-dihydroxyvitamin D in childhood. Acta Endocrinol (Copenh) (1980) 0.98

Origin of nondisjunction in trisomy 8 and trisomy 8 mosaicism. Eur J Hum Genet (1999) 0.97

Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. Blood (1984) 0.96

Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96

[Blood transfusion increases the risk of surgical infection]. Ugeskr Laeger (1993) 0.96

Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br J Cancer (1994) 0.95

Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95

In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res (1998) 0.93

Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood (1991) 0.91

Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome. Leuk Res (1984) 0.91

Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer (2002) 0.89

An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods (1976) 0.89

Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol (1985) 0.89

Dental findings in three siblings with Morquio's syndrome. Int J Paediatr Dent (1999) 0.89

Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction. Eur J Haematol (2002) 0.88

Wegener's granulomatosis. Long-term results of treatment. Ann Otol Rhinol Laryngol (1981) 0.88

The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963-1973. Cancer (1976) 0.88

[Extramedullary manifestations among adult patients with acute lymphoblastic leukemia (ALL)]. Ugeskr Laeger (1991) 0.88

Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer (1999) 0.88

Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target. Leukemia (2013) 0.87

Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. In Vivo (1999) 0.87

13-cis retinoic acid treatment of myelodysplastic syndromes. Leuk Res (1987) 0.86

Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86

Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry. Leuk Lymphoma (1995) 0.85

Risk factors for central nervous system involvement in non-Hodgkins-lymphoma--a multivariate analysis. Acta Oncol (1996) 0.85

A population study of severe aplastic anemia in children. Incidence, etiology and course. Acta Paediatr Scand (1986) 0.85

Parvovirus B19 infection and Diamond-Blackfan anaemia. Acta Paediatr (1996) 0.85

Breast tumour as a first manifestation of extramedullary relapse in acute lymphoblastic leukaemia. Scand J Haematol (1984) 0.84

Identification and cloning of a prethymic precursor T lymphocyte from a population of common acute lymphoblastic leukemia antigen (CALLA)-positive fetal bone marrow cells. J Exp Med (1987) 0.84

Bone marrow examination in non-Hodgkin's lymphoma: comparison of the diagnostic value of marrow aspirations and trephine biopsy. Eur J Haematol (1991) 0.84

Late relapse of adrenocortical carcinoma in Beckwith-Wiedemann syndrome. Clinical, endocrinological and genetic aspects. Acta Paediatr (2003) 0.84

Gastric lymphomas. Clinical features, treatment and prognosis. Acta Radiol Oncol (1984) 0.84

Optimization of a flow cytometric method for the simultaneous measurement of cell surface antigen, DNA content, and in vitro BrdUrd incorporation into normal and malignant hematopoietic cells. Cytometry (1998) 0.84

Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. Blood (1986) 0.83

Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: identification of a group of patients with similar T-cell receptor beta and delta rearrangements and course of disease suggestive of poor prognosis. Blood (1991) 0.83

A two-color flow cytometry assay for detection of hairy cells using monoclonal antibodies. Blood (1987) 0.83

Counterregulation of insulin-induced hypoglycaemia in primary hypothyroidism. Acta Endocrinol (Copenh) (1986) 0.83

Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia. Leuk Lymphoma (2001) 0.83

Effect of hyperthyroidism on fibre-type composition, fibre area, glycogen content and enzyme activity in human skeletal muscle. Clin Physiol (1986) 0.83

Optimization of a method for simultaneous analysis of cell surface phenotype and cell cycle in human bone marrow and peripheral blood leukocytes by flow cytometry: the value of both internal and external standards. Anal Cell Pathol (1993) 0.82

Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia. Leukemia (2001) 0.82

Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia (1996) 0.82

Comparison between 125IUdR and 51Cr as cell labels in investigations of tumor cell migration. Int J Rad Appl Instrum B (1990) 0.82

Benign ureteral polyp as a cause of intermittent hydronephrosis in a child. J Urol (1981) 0.81

No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma. Hum Genet (1996) 0.81

A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry. Leuk Res (1993) 0.81

Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment. Cancer Chemother Pharmacol (1986) 0.81

Otological manifestations of Wegener's granulomatosis. Laryngoscope (1982) 0.81

Disseminated histiocytosis X. A clinical and immunohistochemical retrospective study. Acta Pathol Microbiol Immunol Scand A (1985) 0.80

Immunological studies in chronic lymphocytic leukemia.-II. Natural killer- and antibody-dependent cellular cytotoxicity potentials of malignant and non-malignant lymphocyte subsets and the effect of alpha-interferon. Leuk Res (1981) 0.80

Enumeration of organ-associated natural killer cells in mice: application of a new stereological method. APMIS (1992) 0.80

Detection of mutations in GC-rich DNA by bisulphite denaturing gradient gel electrophoresis. Nucleic Acids Res (1998) 0.79

Natural killer function following allogeneic bone marrow transplantation. Very early reemergence but strong dependence of cytomegalovirus infection. Transplantation (1988) 0.79

Trisomy 10 survival: a literature review and presentation of seven new cases. Cancer Genet Cytogenet (1998) 0.79

Late recurrence of Wilms tumor. Med Pediatr Oncol (1982) 0.79

Effect of recombinant alpha interferon on NK and ADCC function in lung cancer patients: results from a phase II trial. J Interferon Res (1984) 0.79

Malignant monoblasts can function as effector cells in natural killer cell and antibody-dependent cellular cytotoxicity assays. Blood (1981) 0.79

Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia. Eur J Haematol (2003) 0.78

The use of monoclonal antibodies in clinical haematology--the art of limitation. Scand J Haematol (1984) 0.78

Many unbalanced translocations show duplication of a translocation participant. Clinical and cytogenetic implications in myeloid hematologic malignancies. Am J Hematol (2000) 0.78

Interferon-induced augmentation of cytotoxic killer cell generation in mixed lymphocyte cultures: analysis of the effector cell product. Scand J Immunol (1981) 0.78

Selective effects of alpha interferon on human T-lymphocyte subsets during mixed lymphocyte cultures. Scand J Immunol (1983) 0.78

Capnocytophaga (Capnocytophaga ochracea group) bacteremia in hematological patients with profound granulocytopenia. Scand J Infect Dis (1995) 0.78

Relation of blast cell survival and proliferation to chemotherapy resistance in AML. Br J Haematol (1996) 0.78

Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma. Scand J Clin Lab Invest (2001) 0.78

Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO. Ann Oncol (1994) 0.78

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet. Leukemia (2011) 0.78

Biology of multiple drug resistance in acute leukemia. Int J Hematol (2000) 0.77

Human lymphocyte and mouse erythrocyte rosettes. Optimization of the assay. Scand J Haematol (1981) 0.77

Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support. Leuk Lymphoma (1996) 0.77

MDR1 gene expression and drug resistance of AML cells. Br J Haematol (1998) 0.77